Pharmaceutical Logistics Market Analysis

The South America pharmaceutical logistics market is steadily emerging as a high-potential landscape, underpinned by a growing burden of chronic diseases, an expanding middle class, and rising healthcare expenditure across the region. Increased urbanization, changing dietary habits, and an aging population are collectively elevating demand for innovative pharmaceutical products, making efficient and reliable logistics infrastructure more critical than ever. The product spectrum handled across the region spans branded drugs, generic medicines, biologics, vaccines, biosimilars, and over-the-counter formulations, with the biologics and biosimilars segment gaining strong momentum, particularly in oncology, autoimmune disorders, and chronic inflammatory diseases, driven by regulatory reforms and government-backed reimbursement policies. Brazil's ANVISA (National Health Surveillance Agency) and Argentina's ANMAT (Administration National de Medicamentos) set rigorous standards for drug distribution, storage, and transportation. ANVISA has streamlined the approval process for generics, reducing time-to-market and encouraging domestic production while ANMAT has approved several new biosimilars, facilitating broader patient access to high-cost therapies. Governments across the region are also increasingly promoting generic drug adoption through favorable procurement policies to reduce healthcare costs. Despite this promise, the market faces notable structural challenges. The region remains heavily reliant on imported Active Pharmaceutical Ingredients (APIs), primarily from China and India, making supply chains susceptible to global disruptions, geopolitical tensions, and logistical bottlenecks. Cold chain infrastructure, though improving, remains underdeveloped in remote areas.

Emerging technologies such as drone delivery to remote regions, blockchain-enabled traceability, IoT-based cold chain monitoring, and AI-driven demand forecasting are poised to transform the market, while the rapid growth of online pharmacy services and digital health platforms further opens new distribution avenues for logistics players willing to invest in the region's evolving healthcare ecosystem. According to the research report, "South America Pharmaceutical Logistics Market Research Report, 2031," published by Actual Market Research, the South America Pharmaceutical Logistics Market is anticipated to add to more than 2.47 Billion by 2026–31.The South America pharmaceutical logistics market features a moderately concentrated yet increasingly competitive landscape, shaped by the co-existence of global logistics giants and agile regional operators. Dominant multinational players such as DHL Supply Chain, FedEx, UPS, Kuehne + Nagel, CEVA Logistics, DB Schenker, GEODIS, and C.H. Robinson maintain strong footholds across the region, while domestic and specialized providers actively compete in niche segments, particularly cold chain and last-mile distribution. Brazil holds a commanding position as the region's foremost logistics hub, while Argentina has demonstrated consistent pharmaceutical logistics spending growth, making it one of the few industries in that country experiencing steady expansion. Strategic mergers, acquisitions, and collaborations have intensified competition and reshaped the market's structure. In April 2025, DSV completed its acquisition of DB Schenker, creating one of the world's largest logistics groups with significantly expanded South American reach. Simultaneously, DHL Group announced a major global health-logistics expansion, earmarking a substantial portion specifically for the Americas to fund cold-chain and Pharma Hub upgrades. At the regional level, Polar, a DHL Group company specializing in the transportation of medicines, vaccines, and hospital supplies, expanded its fleet in Brazil with multi-temperature trucks, addressing a capability still uncommon in the country's health logistics market. The market's growth trajectory is firmly upward, fueled by rising healthcare demand, expanding generics and biosimilars adoption, and the rapid proliferation of e-commerce pharmacy channels.

Governments and private stakeholders are increasingly exploring localized API production partnerships and strategic stockpiling to reduce this vulnerability. .

Market Dynamic

Pharmaceutical LogisticsSegmentation

Cold-chain logistics is the fastest growing segment in type segmentation in the South America pharmaceutical logistics market because the rising demand for temperature-sensitive biologics, vaccines, and advanced therapies requires specialized handling, storage, and transport solutions to ensure product integrity and patient safety.

Cold-chain logistics is experiencing rapid growth in the South America pharmaceutical logistics market as the region sees increasing production and distribution of temperature-sensitive pharmaceutical products including biologics vaccines insulin and other high-value therapies that must be maintained within strict temperature ranges throughout the supply chain. These products are critical for treating chronic diseases, supporting immunization programs, and meeting emerging healthcare needs, which has created significant demand for reliable cold-chain infrastructure and services. Logistics providers are investing in refrigerated transportation, insulated packaging, temperature-controlled warehouses, and real-time monitoring technologies to address these requirements and ensure compliance with regulatory standards. South American countries are also strengthening regulatory frameworks for pharmaceutical distribution, emphasizing good distribution practices, traceability, and continuous monitoring of temperature-sensitive shipments, which further drives the adoption of cold-chain logistics solutions. In addition, the region is experiencing growth in e-commerce and direct-to-patient delivery models that require sophisticated cold-chain capabilities to maintain drug efficacy during last-mile distribution. While non-cold chain logistics remains significant for stable pharmaceuticals and over-the-counter medicines, it does not require the same level of investment, technology, and operational complexity as cold-chain logistics. Infrastructure development, increased production of biologics, and rising healthcare expenditure across countries such as Brazil, Argentina, and Chile are fueling further expansion in cold-chain services. The growing focus on vaccination programs and the introduction of innovative therapies across South America are further accelerating demand for specialized cold-chain logistics. Additionally, international collaborations and export of temperature-sensitive pharmaceuticals are encouraging investment in advanced infrastructure and technology, reinforcing the segment’s rapid growth.

Acrylic is the fastest growing segment in service segmentation in the South America pharmaceutical logistics market because it provides superior cushioning, thermal insulation, and durability, ensuring safe transport and storage of sensitive pharmaceutical products.

Acrylic foam is rapidly gaining prominence as the fastest growing material in the service segmentation of the South America pharmaceutical logistics market due to its excellent performance characteristics that meet the demanding requirements of modern pharmaceutical supply chains. Pharmaceuticals, especially biologics, vaccines, and other temperature-sensitive or fragile medicines, require packaging solutions that provide reliable impact absorption, moisture resistance, and thermal stability during transit and storage. Acrylic foam is lightweight yet resilient, allowing it to cushion delicate vials, ampoules, and containers against shocks and vibrations that can occur during transportation by road, air, sea, or rail. Its closed-cell structure also prevents moisture penetration, protecting sensitive formulations and ensuring compliance with regulatory standards for product integrity. Logistics providers increasingly prefer acrylic foam for custom inserts, liners, and wraps because it can be easily shaped and adapted to different packaging formats, unlike other foam types such as polyurethane, polyethylene, or neoprene, which may not offer the same combination of cushioning, moisture resistance, and thermal insulation. Additionally, acrylic foam enhances cold-chain efficiency when used with refrigerated shippers, gel packs, or dry ice by reducing thermal loss and helping maintain consistent temperatures, which is critical for maintaining the efficacy of biologics and vaccines. The growing demand for e-commerce delivery of pharmaceuticals and last-mile distribution further supports the adoption of acrylic foam, as secure and protective packaging is essential for reaching patients safely and on time. Sustainability considerations are also influencing the selection of packaging materials, and acrylic foam offers recyclable and durable options that align with environmental goals.

Biopharma is the largest and fastest growing segment in application segmentation in the South America pharmaceutical logistics market because biologics, vaccines, cell and gene therapies, and other advanced medicines require specialized temperature-controlled handling and high-value distribution, and their demand is rapidly increasing across the region.

The biopharma segment dominates the application segmentation in the South America pharmaceutical logistics market due to the rapid expansion of biologics, vaccines, cell and gene therapies, and other high-value innovative medicines that are increasingly used to treat chronic diseases, rare disorders, and emerging health challenges. These products are highly sensitive to temperature fluctuations and require strict cold chain logistics, real-time monitoring, and validated handling procedures from manufacturing facilities to hospitals, retail pharmacies, and direct-to-patient distribution channels. The increasing adoption of advanced therapies in countries such as Brazil, Argentina, Chile, and other South American markets has significantly raised the complexity and volume of pharmaceutical shipments, driving demand for logistics providers capable of maintaining product integrity and complying with regulatory requirements. Regulatory authorities in the region enforce good distribution practices, traceability, serialization, and strict temperature compliance, making specialized logistics services essential for ensuring safety and efficacy. Compared to chemical pharmaceuticals and specialty drugs, which are generally stable at ambient temperatures and easier to transport, biopharmaceutical products have higher operational and financial value, necessitating investment in advanced cold storage, transportation technology, and digital monitoring systems. Additionally, the growth of public immunization programs, personalized medicine initiatives, and precision therapies further increases the demand for reliable and efficient biopharma logistics, as maintaining the quality of these treatments is critical for patient outcomes. Cross-border trade within the region and international exports also require sophisticated logistics networks capable of adhering to multiple regulatory frameworks. The rising investment in cold chain infrastructure and digital tracking technologies by logistics providers further reinforces the growth of biopharma, ensuring safe and efficient distribution across South America.

Contract Manufacturing and Research Organizations is the fastest growing end-user segment in the South America pharmaceutical logistics market because pharmaceutical companies are increasingly outsourcing production and research activities to specialized third-party organizations to reduce costs, accelerate development, and ensure regulatory compliance.

Contract Manufacturing and Research Organizations (CMROs) have emerged as the fastest growing end-user segment in the South America pharmaceutical logistics market as more pharmaceutical and biotechnology companies choose to outsource stages of drug development, formulation, packaging, and clinical trial logistics to specialized third-party providers. These organizations offer scalable production capacity, technical expertise, and regulatory knowledge that many pharmaceutical companies find challenging to maintain in-house, particularly for biologics, vaccines, and high-value therapies. By outsourcing, pharmaceutical companies can focus on core activities such as research, marketing, and commercialization while relying on CMROs to handle complex manufacturing and distribution operations efficiently. The rise of CMROs has significantly increased demand for logistics services that support the secure and compliant movement of raw materials, active pharmaceutical ingredients, intermediates, and finished products across multiple sites and countries. Regulatory compliance is critical in this segment, as CMROs must adhere to stringent good manufacturing practices, serialization, traceability, and temperature-controlled handling, which drives investment in advanced cold chain logistics, real-time monitoring, and validated storage solutions. Additionally, the growth of clinical trials and early-stage research activities across South America has created additional requirements for transporting sensitive samples, investigational drugs, and trial materials under strict conditions, further boosting logistics demand. In comparison, healthcare providers, retail pharmacies, and pharmaceutical and biotechnology companies generally use logistics services for routine supply and distribution, which involves lower volumes and less operational complexity. The increasing reliance on outsourcing for production, research, and specialized services ensures that Contract Manufacturing and Research Organizations remain the fastest growing end-user segment in the South America pharmaceutical logistics market, driving innovation, infrastructure development, and higher-value logistics solutions.

Pharmaceutical Logistics Market Regional Insights

Colombia is the fastest growing market in the South America pharmaceutical logistics industry because of its expanding healthcare infrastructure, increasing pharmaceutical production, and rising adoption of advanced therapies that drive demand for specialized logistics and cold chain solutions.

Colombia is emerging as the fastest growing pharmaceutical logistics market in South America due to a combination of factors that are transforming the country’s healthcare and pharmaceutical landscape. The nation has been investing significantly in healthcare infrastructure, including hospitals, clinics, distribution centers, and retail pharmacy networks, which has created a growing need for reliable and efficient logistics services to transport, store, and deliver pharmaceutical products safely across its diverse geography. The expansion of domestic pharmaceutical manufacturing, particularly in biologics, vaccines, and specialty therapies, further increases the volume and complexity of shipments, driving demand for advanced cold chain logistics, real-time monitoring, and validated handling procedures to maintain product integrity and comply with regulatory standards. Regulatory authorities in Colombia enforce good distribution practices, serialization, and traceability, ensuring that pharmaceutical companies and logistics providers implement systems that guarantee safety, quality, and compliance throughout the supply chain. Additionally, Colombia’s strategic geographic location and improving transport infrastructure facilitate both domestic distribution and regional export of pharmaceutical products, making the logistics sector critical for supporting trade across South America. Rising healthcare expenditure, growing prevalence of chronic diseases, and the introduction of innovative therapies are also contributing to higher demand for specialized pharmaceutical logistics, including temperature-controlled storage and last-mile delivery solutions. The integration of digital technologies, such as GPS tracking, Internet of Things sensors, and automated warehouse management, further enhances supply chain efficiency, accuracy, and compliance. The increasing focus on vaccination campaigns and the growing e-commerce distribution of pharmaceuticals are further accelerating the demand for reliable logistics solutions. Additionally, partnerships between local and international logistics providers are enhancing capacity, technology adoption, and service quality, reinforcing Colombia’s rapid growth in the market.